These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 14619527)

  • 1. [Tumor RNA introduction into dendritic cells and Epstein-Barr virus transformed B cells].
    Minami K; Yamaguchi Y; Ohshita A; Kawabuchi Y; Shimizu K; Ohta K; Hihara J; Miyahara E; Toge T
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1813-6. PubMed ID: 14619527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition of Epstein-Barr virus-associated gastric carcinoma cells by cytotoxic T lymphocytes induced in vitro with autologous lymphoblastoid cell line and LMP2-derived, HLA-A24-restricted 9-mer peptide.
    Okugawa K; Itoh T; Kawashima I; Takesako K; Mazda O; Nukaya I; Yano Y; Yamamoto Y; Yamagishi H; Ueda Y
    Oncol Rep; 2004 Oct; 12(4):725-31. PubMed ID: 15375491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells improve the generation of Epstein-Barr virus-specific cytotoxic T lymphocytes for the treatment of posttransplantation lymphoma.
    Wheatley GH; McKinnon KP; Iacobucci M; Mahon S; Gelber C; Lyerly HK
    Surgery; 1998 Aug; 124(2):171-6. PubMed ID: 9706135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells expand Epstein Barr virus specific CD8+ T cell responses more efficiently than EBV transformed B cells.
    Subklewe M; Sebelin K; Block A; Meier A; Roukens A; Paludan C; Fonteneau JF; Steinman RM; Münz C
    Hum Immunol; 2005 Sep; 66(9):938-49. PubMed ID: 16360833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of cytotoxic T lymphocytes against human cancer cell lines using dendritic cell-tumor cell hybrids generated by a newly developed electrofusion technique.
    Imura K; Ueda Y; Hayashi T; Itoh T; Shimizu K; Tamai H; Yano Y; Naito K; Kohara J; Nakane K; Matsuura Y; Takeda A; Takeda T; Kawai K; Yamagishi H
    Int J Oncol; 2006 Sep; 29(3):531-9. PubMed ID: 16865268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Generation of TRiDAK (tumor RNA-introduced dendritic cell-activated killer) cells].
    Ohshita A; Yamaguchi Y; Minami K; Miyahara E; Kawabuchi Y; Shimizu K; Ohta K; Hihara J; Toge T
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1809-12. PubMed ID: 14619526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.
    Nair SK; Heiser A; Boczkowski D; Majumdar A; Naoe M; Lebkowski JS; Vieweg J; Gilboa E
    Nat Med; 2000 Sep; 6(9):1011-7. PubMed ID: 10973321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human dendritic cells pulsed with autologous Epstein-Barr virus transformed B-cell lymphoblastoid cell (BCL) lysate elicit a BCL specific MHC-class II restricted T-cell response.
    Sugano M; Conway TF; Kelleher RJ; Sugiyama Y; Chen FA; Bankert RB; Bernstein SH
    J Exp Clin Cancer Res; 2001 Jun; 20(2):175-82. PubMed ID: 11484971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of Ag-specific cytotoxic T lymphocytes by DC transfected with in vitro transcribed influenza virus matrix protein (M1) mRNA.
    Osman Y; Narita M; Ayres F; Takahashi M; Alldawi L; Tatsuo F; Toba K; Hirohashi T; Aizawa Y
    Cytotherapy; 2003; 5(2):161-8. PubMed ID: 12745578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of antigen-presenting cells using cultured dendritic cells and amplified autologous tumor mRNA.
    Minami K; Yamaguchi Y; Ohshita A; Kawabuchi Y; Ohta K; Hihara J; Toge T
    Oncology; 2005; 69(5):399-407. PubMed ID: 16319511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of tumor-reactive effector lymphocytes using tumor RNA-introduced dendritic cells in gastric cancer patients.
    Ohshita A; Yamaguchi Y; Minami K; Okita R; Toge T
    Int J Oncol; 2006 May; 28(5):1163-71. PubMed ID: 16596232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA loading of leukemic antigens into cord blood-derived dendritic cells for immunotherapy.
    Hsu AK; Kerr BM; Jones KL; Lock RB; Hart DN; Rice AM
    Biol Blood Marrow Transplant; 2006 Aug; 12(8):855-67. PubMed ID: 16864056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cotransfection of dendritic cells with RNA coding for HER-2/neu and 4-1BBL increases the induction of tumor antigen specific cytotoxic T lymphocytes.
    Grünebach F; Kayser K; Weck MM; Müller MR; Appel S; Brossart P
    Cancer Gene Ther; 2005 Sep; 12(9):749-56. PubMed ID: 15877082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient induction of specific cytotoxic T lymphocytes to tumor rejection peptide using functional matured 2 day-cultured dendritic cells derived from human monocytes.
    Tanaka F; Yamaguchi H; Haraguchi N; Mashino K; Ohta M; Inoue H; Mori M
    Int J Oncol; 2006 Nov; 29(5):1263-8. PubMed ID: 17016660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfection of dendritic cells with in vitro-transcribed CMV RNA induces polyclonal CD8+- and CD4+-mediated CMV-specific T cell responses.
    Heine A; Grünebach F; Holderried T; Appel S; Weck MM; Dörfel D; Sinzger C; Brossart P
    Mol Ther; 2006 Feb; 13(2):280-8. PubMed ID: 16219490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral immunization with tumor RNA-pulsed dendritic cells confers antitumor immunity in a C57BL/6 pancreatic murine tumor model.
    Schmidt T; Ziske C; Märten A; Endres S; Tiemann K; Schmitz V; Gorschlüter M; Schneider C; Sauerbruch T; Schmidt-Wolf IG
    Cancer Res; 2003 Dec; 63(24):8962-7. PubMed ID: 14695214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
    Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y
    Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro induced and expanded Epstein Barr virus-specific cytotoxic T lymphocytes can specifically kill nasopharyngeal carcinoma cells].
    Chen LP; Huang JQ; Zhou TC; Zhang SX; Wang JL
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1431-3. PubMed ID: 18753079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes.
    Comoli P; Pedrazzoli P; Maccario R; Basso S; Carminati O; Labirio M; Schiavo R; Secondino S; Frasson C; Perotti C; Moroni M; Locatelli F; Siena S
    J Clin Oncol; 2005 Dec; 23(35):8942-9. PubMed ID: 16204009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific antihepatocellular carcinoma T cells generated by dendritic cells pulsed with hepatocellular carcinoma cell line HepG2 total RNA.
    Zhang L; Zhang H; Liu W; Wang H; Jia J; Si X; Ren J
    Cell Immunol; 2005 Nov; 238(1):61-6. PubMed ID: 16472793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.